Medrad's 3T MRI-compatible infusion technology:
This article was originally published in Clinica
Medrad has received US FDA 510(k) market clearance to expand the use of its magnetic resonance imaging (MRI)-compatible drug infusion system with scanners that have magnet strengths of up to, and including, 3T. Its Continuum technology was introduced in 2002 as the first MRI-compatible infusion system, meeting the need for safe and reliable infusion during MRI procedures in strengths up to 1.5T - the market standard at the time. With the advent of higher strength magnets, Medrad began extensive testing in 3T environments. MRI accessory equipment must meet safety standards and perform without interfering with the quality of medical images. "The clearance for 3T helps us reach new patients with this advanced technology," said Gary Bucciarelli, senior vice-president of the Indianola, Pennsylvania firm's magnetic resonance business unit.
You may also be interested in...
Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.
Krka’s bottom line continues to be stronger than usual, driven by a hike in sales and leaner cost base. Looking to 2021, however, management brought investors back down to earth.
The COVID-19 pandemic has triggered extraordinary levels of collaboration. But competition remains, and many newly created coalitions have yet to be stress tested.